SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Compare Add to Portfolio
2Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 42201
 
 
 
C07K PEPTIDES 2298
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 18133
 
 
 
C07D HETEROCYCLIC COMPOUNDS 13131
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 12107
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12167
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 761
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 485
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4124
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 493

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0212,086 Diagnosis and Treatment of Brain TumorApr 25, 13Jul 30, 15[C12N, A61K, G01N, C07K]
2015/0203,477 COMPOUNDS AND METHODS FOR ACTIVATING THE APOPTOTIC ARM OF THE UNFOLDED PROTEIN RESPONSEJun 18, 13Jul 23, 15[C07D, C07C, A61K]
2015/0051,138 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASESMar 14, 13Feb 19, 15[C07K]
2015/0025,064 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOFAug 29, 12Jan 22, 15[C07D, A61K]
2015/0011,551 SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORSFeb 21, 13Jan 08, 15[C07D]
2014/0335,590 METHODS FOR PROMOTING CELL REPROGRAMMINGApr 18, 14Nov 13, 14[C12N]
2014/0256,753 QUINAZOLINONE ANALOGS AND USE OF QUINAZOLINONE ANALOGS FOR TREATING OR PREVENTING CERTAIN VIRAL INFECTIONSAug 10, 12Sep 11, 14[C07D]
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYDec 17, 13Aug 28, 14[C12N, G01N]
2014/0235,582 HIV REPLICATION INHIBITORSAug 27, 12Aug 21, 14[C07D, A61K]
2014/0134,231 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAMar 15, 13May 15, 14[C12N, C12Q, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,115,170 Methods and compositions related to internalizing RGD peptidesJan 30, 13Aug 25, 15[A61K, C07K]
9,101,671 Methods and compositions related to clot binding compoundsDec 31, 07Aug 11, 15[A61K, B82Y]
9,096,544 Therapeutic compoundsDec 23, 10Aug 04, 15[C07D, A61K]
9,061,079 Peptides that home to atherosclerotic plaques and methods of useJun 22, 12Jun 23, 15[A61K]
9,045,483 Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalinesMay 09, 13Jun 02, 15[C07D, A61K]
9,006,404 Endometriosis cell targeting peptide and uses thereofDec 26, 06Apr 14, 15[C07H, A61K, C07K]
8,987,213 Peptides that selectively home to heart vasculature and related conjugates and methodsNov 27, 13Mar 24, 15[A61K, C07K]
8,951,971 Lymphatic zip codes in tumors and pre-malignant lesionsSep 13, 13Feb 10, 15[A61P, G01N, A61K, B82Y, C07K]
8,937,193 Apogossypolone derivatives as anticancer agentsOct 07, 10Jan 20, 15[C07C]
8,912,136 Methods and compositions related to clot-binding compoundsDec 20, 10Dec 16, 14[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USEABANSep 28, 11Aug 29, 13[C07K]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEABANDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISABANDec 02, 10Jun 20, 13[G01N]
2013/0100,272 Multifunction autofocus system and method for automated microscopyABANOct 25, 11Apr 25, 13[H04N]
2013/0064,799 METHODS FOR PROMOTING CELL REPROGRAMMINGABANMay 31, 12Mar 14, 13[C12N, C40B, G01N, A61K]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESABANFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSABANOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0204,273 COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USEABANDec 22, 11Aug 09, 12[C12N, A01K, A61P, C12Q, G01N, A61K]
2012/0196,922 ZNF206: A NOVEL REGULATOR OF EMBRYONIC STEM CELL SELF-RENEWAL AND PLURIPOTENCYABANDec 05, 11Aug 02, 12[C12N, C07H, C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0190,615 METHODS AND COMPOSITIONS FOR INDUCING WEIGHT LOSSABANJan 18, 12Jul 26, 12[A61P, A61K]
2012/0094,922 SCREENING ASSAYS FOR AGENTS THAT ALTER INHIBITOR OF APOPTOSIS (IAP) PROTEIN REGULATION OF CASPASE ACTIVITYABANNov 02, 11Apr 19, 12[A61P, C12Q, G01N, A61K]
2012/0095,032 METHODS FOR TREATING LEUKEMIA AND MYELODYSPLASTIC SYNDROME, AND METHODS FOR IDENTIFYING AGENTS FOR TREATING SAMEABANDec 06, 11Apr 19, 12[C12N, A61P, A61K]
2012/0095,078 METHODS OF DIAGNOSIS AND TREATMENT OF MELANOMAABANOct 07, 11Apr 19, 12[C40B, A61P, C12Q, A61K]
2012/0088,678 METHOD FOR PREDICTION OF RESPONSE TO RHEUMATOID ARTHRITIS THERAPEUTICSABANSep 08, 11Apr 12, 12[C40B, C12Q, G01N]
2012/0088,771 TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE (TNAP): A THERAPEUTIC TARGET FOR ARTERIAL CALCIFICATIONABANOct 11, 11Apr 12, 12[C07D, A61P, C07C, A61K]
2012/0071,629 APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCERABANJul 20, 11Mar 22, 12[C07H, C07K]
2012/0046,195 DETECTING BCL-B EXPRESSION IN CANCER AND USES THEREOFABANOct 31, 11Feb 23, 12[C40B, C12Q, G01N]
2012/0046,329 MODULATORS OF NOD1 AND NOD2 SIGNALING, METHODS OF IDENTIFYING MODULATORS OF NOD1 AND NOD2 SIGNALING, AND USES THEREOFABANAug 10, 11Feb 23, 12[C12N, C40B, A61P, A61K]
2012/0046,446 p16 MEDIATED REGULATION OF NMDA RECEPTORSABANAug 12, 11Feb 23, 12[C07H, C07K]
2012/0034,164 TRUNCATED CAR PEPTIDES AND METHODS AND COMPOSITIONS USING TRUNCATED CAR PEPTIDESABANSep 01, 11Feb 09, 12[A61P, A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.